Improving customer experience with AI and machine learning
Improving customer experience with AI and machine learning. Richard Gray of IQVIA says it’s all in the mind(set). This year marks an inflection point...
Could blockchain reduce NHS clinical negligence claims?
Dr Amina Albeyatti of MyClinic asks whether blockchain could reduce clinical negligence claims against the NHS. The NHS is one of the best healthcare systems...
GPs and pharmacists are using virtual clinics in primary care
Dr Zubair Ahmed, Co-founder and CEO of Medicspot, looks at how GPs and pharmacists are using virtual clinics in primary care. Since founding Medicspot four...
Embracing AI in pharma sales
The future of pharmaceutical sales will rely increasingly on the combination of technology and data. Rasim Shah, Director of OKRA discusses embracing AI in pharma...
The five trends of a digital pharma future
Neil Osmond, Technologist and Founder of earthware, explores the five trends of a digital pharma future. Human and digital must work together to benefit...
Reducing animal use in biopharmaceuticals
EU directives and animal welfare initiatives keep challenging scientists and industry leaders to change conventional practices. Far from hindering scientific and technological progress, this...
The challenge in retaining pharmacovigilance talent
What more can life sciences firms do to hang on to restless pharmacovigilance talent, as their most valued employees crave broader experience? At a recent industry event...
Medicines access policies in 2020
Top 5 Takeaways The UK wishes to ‘align as closely as possible’ to EU Regulation on medicines.
There are several policies that will create...
Lyme Disease: Finding a treatment for every patient
Rosie Milsom, Fundraising and Communications Manager at Caudwell LymeCo Charity is hoping to find a treatment that works for every patient, at every stage of Lyme disease. What is...
Will 2020 bring an end to drug shortages?
A perfect storm of manufacturing issues and growing global demand led to a nationwide drug shortage that took its toll on clinicians and communication...
Latest articles
People with neurological conditions lose out due to COVID-19 delays
In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Without support for services post COVID-19 mental health crisis awaits
The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
Major study into COVID-19 long-term health effects
The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Crisis or crossroads? Key account management post-COVID
Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
Major study into COVID-19 long-term health effects
The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
European Commission approves extended Invokana ® (canagliflozin) indication
The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...